The FORHP-supported Center on Rural Addiction at the University of Vermont provides information on new federal requirements for outpatient providers prescribing buprenorphine, a medication used to treat opioid use disorder. While no longer needing a waiver from the Drug Enforcement Agency (DEA), clinicians will still be required to register with the DEA to prescribe controlled medications. Beginning on June 27, the DEA registration will require applicants – both new and renewing – to affirm they have completed a new, one-time, eight-hour training. Exceptions for the new training requirement are practitioners who are board certified in addiction medicine or addiction psychiatry, and those who graduated from a medical, dental, physician assistant, or advanced practice nursing school in the U.S. within five years of June 27, 2023.
The post Read About the Updates to Requirements for Buprenorphine Prescribing appeared first on Pennsylvania Office of Rural Health.